Raymond James & Associates Soma Logic, Inc. Transaction History

Raymond James & Associates

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	SELL	$1.76 - $2.83 $8,800 - $14,150	-5,000 Reduced 24.51%	15,400 $38,000
Q3 2023 Oct 24, 2023	BUY	$1.99 - $2.45 $10,149 - $12,495	5,100 Added 33.33%	20,400 $48,000
Q2 2023 Jul 25, 2023	BUY	$2.1 - $3.36 $630 - $1,008	300 Added 2.0%	15,300 $35,000
Q1 2023 Apr 14, 2023	BUY	$2.13 - $3.6 $4,110 - $6,948	1,930 Added 14.77%	15,000 $38,000
Q4 2022 Feb 08, 2023	BUY	$2.05 - $3.47 $26,793 - $45,352	13,070 New	13,070 $32,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.